Answers are grounded in this paper and cite their sources.
CRAFFT has good concurrent validity for problematic substance use and SUD in PED patients and is useful in predicting SUDs at up to 3 years follow-up but with limited sensitivity.
No takes yet. Share an insight, caveat, or question.
Shenoi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: